Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional

A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

ClinicalTrials.gov ID: NCT06957080

Public ClinicalTrials.gov record NCT06957080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 5:05 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Multi-Center, 3-Arm Pivotal Phase 2/3 Study to Evaluate The Efficacy and Safety of Intravitreal EYE103 Compared With Intravitreal Ranibizumab (0.5mg) in Participants With Diabetic Macular Edema

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison with the active control, ranibizumab, in patients with diabetic macular edema (DME). In the first year, all 3 treatment groups will be treated every 4 weeks with either remigromig or ranibizumab. Beginning at Year 2, the frequency of treatment for participants will shift based on a personalized treatment interval algorithm. Approximately 960 participants will be entered in the study.

Study identification

NCT ID
NCT06957080
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
EyeBiotech Ltd.
Industry
Enrollment
1,054 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 16, 2025 (Actual)
Primary completion
Jan 11, 2027 (Estimated)
Completion
Jan 11, 2028 (Estimated)
Last update posted
Oct 30, 2026

2025 – 2028

United States locations

U.S. sites
107
U.S. states
29
U.S. cities
99
Facility City State ZIP Site status
Gilbert, Arizona Gilbert Arizona 85297 —
Phoenix, Arizona Phoenix Arizona 85020 —
Scottsdale, AZ Scottsdale Arizona 85255 —
Fayetteville, AR Fayetteville Arkansas 72703 —
Bakersfield, CA Bakersfield California 93309 —
Encino, California Encino California 91436 —
Modesto, CA Modesto California 95356 —
Mountain View, CA Mountain View California 94040 —
Redlands, CA Redlands California 92374 —
Sacramento, CA Sacramento California 95825 —
Sacramento, CA Sacramento California 95841 —
Santa Ana, CA Santa Ana California 92705 —
Santa Ana Santa Ana California 92705 —
Colorado Springs, CO Colorado Springs Colorado 80909 —
Denver, CO Denver Colorado 80012 —
Durango, CO Durango Colorado 81303 —
Danbury, CT Danbury Connecticut 06810 —
Manchester, CT Manchester Connecticut 06042 —
Waterford, CT Waterford Connecticut 06385 —
Waterford,CT Waterford Connecticut 06385 —
Deerfield Beach, FL Deerfield Beach Florida 33064 —
Fort Lauderdale, FL Fort Lauderdale Florida 33308 —
Fort Myers, FL Fort Myers Florida 33912 —
Gainesville, FL Gainesville Florida 32607 —
Orlando, FL Orlando Florida 32806 —
Plantation, FL Plantation Florida 33324 —
Sarasota, FL Sarasota Florida 34232 —
Saint Petersburg, FL St. Petersburg Florida 33711 —
Tallahassee, FL Tallahassee Florida 32308 —
Tampa, FL Tampa Florida 33609 —
Tampa, FL Tampa Florida 33617 —
Winter Haven, FL Winter Haven Florida 33880 —
Joliet, Illinois Joliet Illinois 60435 —
Lemont, IL Lemont Illinois 60439 —
Oak Park, IL Oak Park Illinois 60304 —
Springfield, IL Springfield Illinois 62702 —
West Des Moines, IA West Des Moines Iowa 50266 —
Lenexa, KS Lenexa Kansas 66215 —
Wichita, Kansas Wichita Kansas 67214 —
Portland, ME Portland Maine 04101 —
Baltimore, Maryland Baltimore Maryland 21209 —
Hagerstown, MD Hagerstown Maryland 21740 —
Towson, MD Towson Maryland 21204 —
Springfield,MA Springfield Massachusetts 01107 —
Grand Rapids, MI Grand Rapids Michigan 49546 —
Edina, MN Edina Minnesota 55435 —
Minneapolis, MN Minneapolis Minnesota 55435 —
Madison, MS Madison Mississippi 39110 —
Henderson, Nevada Henderson Nevada 89052 —
Bloomfield, NJ Bloomfield New Jersey 07003 —
Cherry Hill, NJ Cherry Hill New Jersey 08034 —
Albuquerque, New Mexico Albuquerque New Mexico 87109 —
Great Neck, New York Great Neck New York 11021 —
Hauppauge, New York Hauppauge New York 11788 —
Liverpool, NY Liverpool New York 13088 —
New York, NY New York New York 10022 —
Rochester, NY Rochester New York 14620 —
Asheville, NC Asheville North Carolina 28803 —
Cary, North Carolina Cary North Carolina 27511 —
Hickory, NC Hickory North Carolina 28602 —
Wake Forest, NC Wake Forest North Carolina 27587 —
Winston Salem, NC Winston-Salem North Carolina 27103 —
Winston-Salem, NC Winston-Salem North Carolina 27103 —
Tulsa, Oklahoma Tulsa Oklahoma 74114 —
Portland, OR Portland Oregon 97221 —
Portland, Oregon Portland Oregon 97225 —
Salem, Oregon Salem Oregon 97302 —
Springfield, OR Springfield Oregon 97477 —
Bethlehem, PA Bethlehem Pennsylvania 18017 —
Erie, PA Erie Pennsylvania 16507 —
Aiken, SC Aiken South Carolina 29802 —
Beaufort, NC Beaufort South Carolina 29902 —
Beaufort, SC Beaufort South Carolina 29902 —
Bluffton, NC Bluffton South Carolina 29910 —
Charleston, SC Charleston South Carolina 29414 —
Florence, SC Florence South Carolina 29501 —
Ladson, NC Ladson South Carolina 29456 —
Ladson, SC Ladson South Carolina 29456 —
West Columbia, SC West Columbia South Carolina 29169 —
Germantown, TN Germantown Tennessee 38138 —
Hixson, TN Hixson Tennessee 37343 —
Johnson City, TN Johnson City Tennessee 37604 —
Knoxville, TN Knoxville Tennessee 37922 —
Nashville, TN Nashville Tennessee 37203 —
Abilene, TX Abilene Texas 79606 —
Amarillo, TX Amarillo Texas 79106 —
Arlington, TX Arlington Texas 76012 —
Austin, TX Austin Texas 78705 —
Bellaire, TX Bellaire Texas 77401 —
Burleson, Texas Burleson Texas 76028 —
Dallas, TX Dallas Texas 75231 —
Fort Worth, TX Fort Worth Texas 76104 —
Katy, TX Katy Texas 77494 —
Plano, TX Plano Texas 75075 —
Round Rock, TX Round Rock Texas 78681 —
San Antonio, TX San Antonio Texas 78240 —
San Marcos, Texas San Marcos Texas 78666 —
Schertz, TX Schertz Texas 78154 —
The Woodlands, TX The Woodlands Texas 77384 —
Willow Park, TX Willow Park Texas 76087 —
Salt Lake City, UT Salt Lake City Utah 84107 —
West Jordan, Utah West Jordan Utah 84088 —
Lynchburg, VA Lynchburg Virginia 24502 —
Richmond, VA Richmond Virginia 23235 —
Bellevue, Washington Bellevue Washington 98004 —
Burlington, Washington Burlington Washington 98233 —
Spokane, WA Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06957080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06957080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →